Citius Pharmaceuticals News - CTXR

Company Name	Stock Ticker Symbol	Market	Type
Citius Pharmaceuticals Inc	CTXR	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.0406	-5.54%	0.692	07:00:32

Open Price	Low Price	High Price	Close Price	Prev Close
				0.7326

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/11/2024	08:30	PRNUS	Citius Pharmaceuticals Announces Addition of City of Hope to..
4/04/2024	08:30	PRNUS	Citius Pharmaceuticals to Present at the LD Micro..
3/18/2024	08:30	PRNUS	Citius Pharmaceuticals Announces FDA Acceptance of the BLA..
3/07/2024	08:30	PRNUS	Citius Pharmaceuticals, Inc. Secures $2.4 million through..
3/04/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2/26/2024	07:30	PRNUS	Citius Pharmaceuticals Announces Filing of Form S-3 Shelf..
2/23/2024	16:23	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2/23/2024	16:18	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2/23/2024	08:30	PRNUS	Citius Pharmaceuticals to Participate in Upcoming BIO CEO..
2/15/2024	08:45	EDGAR2	Form 8-K - Current report
2/14/2024	16:40	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/14/2024	16:30	PRNUS	Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter..
2/14/2024	09:18	EDGAR2	Form 8-K - Current report
2/14/2024	08:01	PRNUS	Citius Pharmaceuticals Resubmits the Biologics License..
1/26/2024	16:08	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
1/26/2024	16:05	EDGAR2	Form DEF 14A - Other definitive proxy statements
1/23/2024	16:05	EDGAR2	Form 8-K - Current report
1/23/2024	08:30	PRNUS	Citius Pharmaceuticals Announces Nomination of..
1/05/2024	16:05	EDGAR2	Form 8-K - Current report
1/02/2024	16:04	EDGAR2	Form 8-K - Current report
1/02/2024	08:31	PRNUS	Citius Pharmaceuticals Completes Enrollment in Pivotal Phase..
1/02/2024	08:30	PRNUS	Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023..
12/29/2023	16:05	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/09/2023	08:30	PRNUS	Citius Pharmaceuticals to Participate in the Sidoti..
10/31/2023	08:45	PRNUS	Citius Pharmaceuticals Announces Publication in Frontiers of..
10/24/2023	07:58	EDGAR2	Form 425 - Prospectuses and communications, business..
10/24/2023	07:53	EDGAR2	Form 8-K - Current report
10/24/2023	07:30	GLOBE	Citius Pharmaceuticals Executes Definitive Agreement to..
10/12/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/12/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/12/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/12/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/25/2023	16:30	EDGAR2	Form 8-K - Current report
9/21/2023	09:35	GLOBE	Dawson James Securities Announces October Date for 8th..
9/18/2023	16:30	PRNUS	Citius Pharmaceuticals Reschedules Participation in Sidoti..
9/15/2023	16:30	EDGAR2	Form 8-K - Current report
9/13/2023	16:30	PRNUS	Citius Pharmaceuticals Mourns the Loss of Board Member,..
9/11/2023	09:53	EDGAR2	Form 8-K - Current report
9/08/2023	08:40	EDGAR2	Form 8-K - Current report
9/08/2023	08:00	PRNUS	Citius Pharmaceuticals, Inc. Receives Regulatory Guidance..
9/06/2023	16:30	PRNUS	Citius Pharmaceuticals to Participate in H.C. Wainwright and..
8/15/2023	09:25	EDGAR2	Form 8-K - Current report
8/14/2023	16:15	PRNUS	Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter..
8/14/2023	16:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:15	EDGAR2	Form 8-K - Current report
8/10/2023	08:37	PRNUS	Citius Pharmaceuticals Reaches 92 Event Milestone in..
7/31/2023	16:15	EDGAR2	Form 8-K - Current report
7/29/2023	16:16	PRNUS	Citius Pharmaceuticals, Inc. Receives a Complete Response..
6/29/2023	16:15	EDGAR2	Form 8-K - Current report
6/26/2023	08:30	PRNUS	Citius Pharmaceuticals to be Added to Russell 3000® and..